Re-engagement, quality of life, and burden of treatment in adults on dupilumab for severe atopic dermatitis-A mixed methods study.
Emma PorterCathal O'ConnorMichelle MurphyPublished in: Skin health and disease (2024)
The emergence of novel effective treatments for AD has significant implications for dermatology workforce and financial planning.